{ "responseHeader":{ "status":0, "QTime":0, "params":{ "q":"iati_identifier:GB-GOV-10-EDCTP2", "fl":"*", "format":"json" } }, "response":{ "numFound":1, "start":0, "numFoundExact":true, "docs":[{ "default-currency":"GBP", "default_currency":"GBP", "hierarchy":1, "humanitarian":false, "last-updated-datetime":"2026-03-25T11:12:22.540Z", "last_updated_datetime":"Wed Mar 25 11:12:22 UTC 2026", "last_updated_datetime_f":"2026-03-25T11:12:22.540Z", "lang":"en", "default_lang":"en", "iati-identifier":"GB-GOV-10-EDCTP2", "iati_identifier":"GB-GOV-10-EDCTP2", "reporting-org.ref":"GB-GOV-10", "reporting_org_ref":"GB-GOV-10", "reporting-org.type":"10", "reporting_org_type_code":"10", "reporting-org.narrative":["UK - Department of Health and Social Care (DHSC)"], "reporting_org_narrative":["UK - Department of Health and Social Care (DHSC)"], "reporting-org.narrative.lang":[" "], "title.narrative":["European and Developing Countries Clinical Trials Partnership (EDCTP) phase II"], "title_narrative":["European and Developing Countries Clinical Trials Partnership (EDCTP) phase II"], "title_narrative_text":["European and Developing Countries Clinical Trials Partnership (EDCTP) phase II"], "title.narrative.lang":[" "], "title_narrative_lang":[" "], "description.type":["1","2"], "description_type":["1","2"], "description.narrative":["The UK Department of Health and Social Care (DHSC) funds outstanding global health research through the National Institute for Health and Care Research (NIHR). The NIHR provided funding to the European and Developing Countries Clinical Trials Partnership (EDCTP) which aims to support collaborative research that accelerates the clinical development of new or improved interventions to prevent or treat poverty related diseases as well as emerging and re-emerging infectious diseases affecting sub-Saharan Africa. The NIHR has supported research calls as part of the 2016, 2017 and 2018 workplans, in addition to programme management activities associated with enhancing the wider programme.","1) Increase the number of new or improved medical interventions for poverty-related diseases (PRDs), including neglected ones; 2) Strengthen cooperation with sub-Saharan African countries, in particular on building their capacity for conducting clinical trials in compliance with fundamental ethical principles and relevant national, EU and international legislation; 3) Better coordinate, align and, where appropriate, integrate relevant national programmes to increase the cost-effectiveness of European public investments; 4) Extend international cooperation with other public and private partners to ensure that the impact of all research is maximised and that synergies can be taken into consideration and to achieve leveraging of resources and investments; 5) Increase impact due to effective cooperation with relevant EU initiatives, including its development assistance."], "description_narrative":["The UK Department of Health and Social Care (DHSC) funds outstanding global health research through the National Institute for Health and Care Research (NIHR). The NIHR provided funding to the European and Developing Countries Clinical Trials Partnership (EDCTP) which aims to support collaborative research that accelerates the clinical development of new or improved interventions to prevent or treat poverty related diseases as well as emerging and re-emerging infectious diseases affecting sub-Saharan Africa. The NIHR has supported research calls as part of the 2016, 2017 and 2018 workplans, in addition to programme management activities associated with enhancing the wider programme.","1) Increase the number of new or improved medical interventions for poverty-related diseases (PRDs), including neglected ones; 2) Strengthen cooperation with sub-Saharan African countries, in particular on building their capacity for conducting clinical trials in compliance with fundamental ethical principles and relevant national, EU and international legislation; 3) Better coordinate, align and, where appropriate, integrate relevant national programmes to increase the cost-effectiveness of European public investments; 4) Extend international cooperation with other public and private partners to ensure that the impact of all research is maximised and that synergies can be taken into consideration and to achieve leveraging of resources and investments; 5) Increase impact due to effective cooperation with relevant EU initiatives, including its development assistance."], "description_narrative_text":["The UK Department of Health and Social Care (DHSC) funds outstanding global health research through the National Institute for Health and Care Research (NIHR). The NIHR provided funding to the European and Developing Countries Clinical Trials Partnership (EDCTP) which aims to support collaborative research that accelerates the clinical development of new or improved interventions to prevent or treat poverty related diseases as well as emerging and re-emerging infectious diseases affecting sub-Saharan Africa. The NIHR has supported research calls as part of the 2016, 2017 and 2018 workplans, in addition to programme management activities associated with enhancing the wider programme.","1) Increase the number of new or improved medical interventions for poverty-related diseases (PRDs), including neglected ones; 2) Strengthen cooperation with sub-Saharan African countries, in particular on building their capacity for conducting clinical trials in compliance with fundamental ethical principles and relevant national, EU and international legislation; 3) Better coordinate, align and, where appropriate, integrate relevant national programmes to increase the cost-effectiveness of European public investments; 4) Extend international cooperation with other public and private partners to ensure that the impact of all research is maximised and that synergies can be taken into consideration and to achieve leveraging of resources and investments; 5) Increase impact due to effective cooperation with relevant EU initiatives, including its development assistance."], "description.narrative.lang":[" "," "], "description_narrative_lang":[" "," "], "participating-org.ref":["GB-GOV-10","GB-GOV-10","GB-GOV-10","NL-KVK-60471700","NL-KVK-60471700","NL-KVK-60471700","NL-KVK-60471700","NL-KVK-60471700","NL-KVK-60471700","NL-KVK-60471700","NL-KVK-60471700"], "participating_org_ref":["GB-GOV-10","GB-GOV-10","GB-GOV-10","NL-KVK-60471700","NL-KVK-60471700","NL-KVK-60471700","NL-KVK-60471700","NL-KVK-60471700","NL-KVK-60471700","NL-KVK-60471700","NL-KVK-60471700"], "participating-org.role":["1","2","3","4","4","4","4","4","4","4","4"], "participating_org_role":["1","2","3","4","4","4","4","4","4","4","4"], "participating-org.type":["10","10","10","30","30","30","30","30","30","30","30"], "participating_org_type":["10","10","10","30","30","30","30","30","30","30","30"], "participating-org.narrative":["UK - Department of Health and Social Care (DHSC)","UK - Department of Health and Social Care (DHSC)","UK - Department of Health and Social Care (DHSC)","European and Developing Countries Clinical Trials Partnership (EDCTP)","European and Developing Countries Clinical Trials Partnership (EDCTP)","European and Developing Countries Clinical Trials Partnership (EDCTP)","European and Developing Countries Clinical Trials Partnership (EDCTP)","European and Developing Countries Clinical Trials Partnership (EDCTP)","European and Developing Countries Clinical Trials Partnership (EDCTP)","European and Developing Countries Clinical Trials Partnership (EDCTP)","European and Developing Countries Clinical Trials Partnership (EDCTP)"], "participating_org_narrative":["UK - Department of Health and Social Care (DHSC)","UK - Department of Health and Social Care (DHSC)","UK - Department of Health and Social Care (DHSC)","European and Developing Countries Clinical Trials Partnership (EDCTP)","European and Developing Countries Clinical Trials Partnership (EDCTP)","European and Developing Countries Clinical Trials Partnership (EDCTP)","European and Developing Countries Clinical Trials Partnership (EDCTP)","European and Developing Countries Clinical Trials Partnership (EDCTP)","European and Developing Countries Clinical Trials Partnership (EDCTP)","European and Developing Countries Clinical Trials Partnership (EDCTP)","European and Developing Countries Clinical Trials Partnership (EDCTP)"], "participating_org_narrative_text":["UK - Department of Health and Social Care (DHSC)","UK - Department of Health and Social Care (DHSC)","UK - Department of Health and Social Care (DHSC)","European and Developing Countries Clinical Trials Partnership (EDCTP)","European and Developing Countries Clinical Trials Partnership (EDCTP)","European and Developing Countries Clinical Trials Partnership (EDCTP)","European and Developing Countries Clinical Trials Partnership (EDCTP)","European and Developing Countries Clinical Trials Partnership (EDCTP)","European and Developing Countries Clinical Trials Partnership (EDCTP)","European and Developing Countries Clinical Trials Partnership (EDCTP)","European and Developing Countries Clinical Trials Partnership (EDCTP)"], "participating-org.narrative.lang":[" "," "," "," "," "," "," "," "," "," "," "], "participating_org_narrative_lang":[" "," "," "," "," "," "," "," "," "," "," "], "activity-status.code":"2", "activity_status_code":"2", "activity-date.iso-date":["2017-11-07T00:00:00Z","2017-11-07T00:00:00Z","2027-03-31T00:00:00Z"], "activity_date_iso_date":["2017-11-07T00:00:00Z","2017-11-07T00:00:00Z","2027-03-31T00:00:00Z"], "activity-date.type":["1","2","3"], "activity_date_type":["1","2","3"], "contact-info.type":["1"], "contact_info_type":["1"], "contact-info.organisation.narrative":["UK - Department of Health and Social Care (DHSC)"], "contact_info_organisation_narrative":["UK - Department of Health and Social Care (DHSC)"], "contact_info_organisation_narrative_text":["UK - Department of Health and Social Care (DHSC)"], "contact-info.organisation.narrative.lang":[" "], "contact_info_organisation_narrative_lang":[" "], "contact-info.department.narrative":["Science, Research and Evidence"], "contact_info_department_narrative":["Science, Research and Evidence"], "contact_info_department_narrative_text":["Science, Research and Evidence"], "contact-info.department.narrative.lang":[" "], "contact_info_department_narrative_lang":[" "], "contact-info.person-name.narrative":["Global Health Research Programme"], "contact_info_person_name_narrative":["Global Health Research Programme"], "contact_info_person_name_narrative_text":["Global Health Research Programme"], "contact-info.person-name.narrative.lang":[" "], "contact_info_person_name_narrative_lang":[" "], "contact-info.email":["GlobalHealthResearch@dhsc.gov.uk"], "contact_info_email":["GlobalHealthResearch@dhsc.gov.uk"], "contact-info.website":["https://www.nihr.ac.uk/funding-and-support/global-health-research/"], "contact_info_website":["https://www.nihr.ac.uk/funding-and-support/global-health-research/"], "contact-info.mailing-address.narrative":["7th Floor South Wing, 39 Victoria Street, London, SW1H 0EU"], "contact_info_mailing_address_narrative":["7th Floor South Wing, 39 Victoria Street, London, SW1H 0EU"], "contact_info_mailing_address_narrative_text":["7th Floor South Wing, 39 Victoria Street, London, SW1H 0EU"], "contact-info.mailing-address.narrative.lang":[" "], "contact_info_mailing_address_narrative_lang":[" "], "activity-scope.code":"2", "activity_scope_code":"2", "recipient-region.code":["998"], "recipient_region_code":["998"], "recipient-region.vocabulary":["1"], "recipient_region_vocabulary":["1"], "sector.code":["12182"], "sector_code":["12182"], "sector.percentage":[100.0], "sector_percentage":[100.0], "sector.vocabulary":["1"], "sector_vocabulary":["1"], "sector.narrative":["Medical research"], "sector_narrative":["Medical research"], "sector_narrative_text":["Medical research"], "sector.narrative.lang":[" "], "sector_narrative_lang":[" "], "tag.code":["RI"], "tag_code":["RI"], "tag.vocabulary":["99"], "tag_vocabulary":["99"], "tag.vocabulary-uri":["https://devtracker.fcdo.gov.uk/custom-codes"], "tag_vocabulary_uri":["https://devtracker.fcdo.gov.uk/custom-codes"], "tag.narrative":["Research and Innovation"], "tag_narrative":["Research and Innovation"], "tag_narrative_text":["Research and Innovation"], "tag.narrative.lang":[" "], "tag_narrative_lang":[" "], "collaboration-type.code":"1", "collaboration_type_code":"1", "default-flow-type.code":"10", "default_flow_type_code":"10", "default-finance-type.code":"110", "default_finance_type_code":"110", "default-aid-type.code":["C01"], "default_aid_type":["C01"], "default_aid_type_category_code":["C01"], "default_aid_type_code":["C01"], "default-tied-status.code":"5", "default_tied_status_code":"5", "capital-spend.percentage":100.0, "capital_spend_percentage":100.0, "document-link.format":["application/pdf","text/html","application/pdf","application/pdf","application/pdf","application/pdf","application/pdf","application/pdf","application/pdf","text/html","application/pdf"], "document_link_format":["application/pdf","text/html","application/pdf","application/pdf","application/pdf","application/pdf","application/pdf","application/pdf","application/pdf","text/html","application/pdf"], "document-link.url":["http://www.edctp.org/web/app/uploads/2018/09/Tackling-infectious-disease-in-sub-Saharan-Africa_EDCTP-funded-clinical-studies-for-medical-interventions-2003-2018-4.pdf","http://www.edctp.org/","https://drive.google.com/open?id=1vwm9Vtpday3tGQbCO2lRlmhUB8xM9Rqd&usp=drive_copy","https://drive.google.com/file/d/1gKjBMegVAsBuyERmpqiDEgK0C-dBGmxF/view?usp=drive_link","https://drive.google.com/open?id=1SbewTAkqcYirhwnehs4gNHznKX9ssZy1&usp=drive_copy","https://drive.google.com/file/d/15sPEqysmGVYx1GOMrGsL0GXkyEVRoP8l/view?usp=drive_link","https://drive.google.com/open?id=1ousH2dKnWWBzuFpJuDFuAg5TBxfu_o8M&usp=drive_copy","https://drive.google.com/file/d/1BUnsAUNnRVLEuLbkhPHPPBJE-W7S37tQ/view?usp=drive_link","https://drive.google.com/open?id=1PdErJJpupm0rsFpEHypFzPd01LQ5LHLK&usp=drive_copy","http://www.edctp.org/projects-2/edctp2-projects/","https://drive.google.com/file/d/1TcFegu9QL5i3h7EIzUWIous4Ci2zLVoM/view?usp=drive_link"], "document_link_url":["http://www.edctp.org/web/app/uploads/2018/09/Tackling-infectious-disease-in-sub-Saharan-Africa_EDCTP-funded-clinical-studies-for-medical-interventions-2003-2018-4.pdf","http://www.edctp.org/","https://drive.google.com/open?id=1vwm9Vtpday3tGQbCO2lRlmhUB8xM9Rqd&usp=drive_copy","https://drive.google.com/file/d/1gKjBMegVAsBuyERmpqiDEgK0C-dBGmxF/view?usp=drive_link","https://drive.google.com/open?id=1SbewTAkqcYirhwnehs4gNHznKX9ssZy1&usp=drive_copy","https://drive.google.com/file/d/15sPEqysmGVYx1GOMrGsL0GXkyEVRoP8l/view?usp=drive_link","https://drive.google.com/open?id=1ousH2dKnWWBzuFpJuDFuAg5TBxfu_o8M&usp=drive_copy","https://drive.google.com/file/d/1BUnsAUNnRVLEuLbkhPHPPBJE-W7S37tQ/view?usp=drive_link","https://drive.google.com/open?id=1PdErJJpupm0rsFpEHypFzPd01LQ5LHLK&usp=drive_copy","http://www.edctp.org/projects-2/edctp2-projects/","https://drive.google.com/file/d/1TcFegu9QL5i3h7EIzUWIous4Ci2zLVoM/view?usp=drive_link"], "document-link.title.narrative":["2003- 2018 review ","Activity webpage ","DHSC contribution to EDCTP Report - 1 Jan 2018 to 30 Apr 2020","EDCTP Phase 2 and 3 2023-2025 Annual Review","EDCTP2 Annual Review 2020-2021","EDCTP2 Annual Review 2020-21","EDCTP2 Annual Review 2021-2022","EDCTP2 Annual Review 2021-22","Memorandum of Understanding","Projects by call for proposal","GHR Portfolio Evaluation"], "document_link_title_narrative":["2003- 2018 review ","Activity webpage ","DHSC contribution to EDCTP Report - 1 Jan 2018 to 30 Apr 2020","EDCTP Phase 2 and 3 2023-2025 Annual Review","EDCTP2 Annual Review 2020-2021","EDCTP2 Annual Review 2020-21","EDCTP2 Annual Review 2021-2022","EDCTP2 Annual Review 2021-22","Memorandum of Understanding","Projects by call for proposal","GHR Portfolio Evaluation"], "document_link_title_narrative_text":["2003- 2018 review ","Activity webpage ","DHSC contribution to EDCTP Report - 1 Jan 2018 to 30 Apr 2020","EDCTP Phase 2 and 3 2023-2025 Annual Review","EDCTP2 Annual Review 2020-2021","EDCTP2 Annual Review 2020-21","EDCTP2 Annual Review 2021-2022","EDCTP2 Annual Review 2021-22","Memorandum of Understanding","Projects by call for proposal","GHR Portfolio Evaluation"], "document-link.title.narrative.lang":[" "," "," "," "," "," "," "," "," "," "," "], "document_link_title_narrative_lang":[" "," "," "," "," "," "," "," "," "," "," "], "document-link.category.code":["A07","A08","A12","A07","A08","A07","A08","A02","A05","A07","A08","A07","A08","A07","A08","A07","A08","A09","A04","A06","A07"], "document_link_category_code":["A07","A08","A12","A07","A08","A07","A08","A02","A05","A07","A08","A07","A08","A07","A08","A07","A08","A09","A04","A06","A07"], "document-link.language.code":["en","en","en","en","en","en","en","en","en","en","en"], "document_link_language_code":["en","en","en","en","en","en","en","en","en","en","en"], "document-link.document-date.iso-date":["2017-11-07T00:00:00Z","2017-11-07T00:00:00Z","2020-11-11T00:00:00Z","2025-05-26T00:00:00Z","2024-01-17T00:00:00Z","2024-07-01T00:00:00Z","2024-01-17T00:00:00Z","2024-07-01T00:00:00Z","2023-12-08T00:00:00Z","2017-11-07T00:00:00Z","2024-03-01T00:00:00Z"], "document_link_document_date_iso_date":["2017-11-07T00:00:00Z","2017-11-07T00:00:00Z","2020-11-11T00:00:00Z","2025-05-26T00:00:00Z","2024-01-17T00:00:00Z","2024-07-01T00:00:00Z","2024-01-17T00:00:00Z","2024-07-01T00:00:00Z","2023-12-08T00:00:00Z","2017-11-07T00:00:00Z","2024-03-01T00:00:00Z"], "related-activity.ref":["GB-GOV-10-EDCTP2_2016WP","GB-GOV-10-EDCTP2_2017WP","GB-GOV-10-EDCTP2_2018WP","GB-GOV-10-EDCTP2_2020WP","GB-GOV-10-EDCTP2_2024WP","GB-GOV-10-EDCTP2_PM","GB-GOV-10-EDCTP2_Scheme7","GB-GOV-10-EDCTP2_Scheme8"], "related_activity_ref":["GB-GOV-10-EDCTP2_2016WP","GB-GOV-10-EDCTP2_2017WP","GB-GOV-10-EDCTP2_2018WP","GB-GOV-10-EDCTP2_2020WP","GB-GOV-10-EDCTP2_2024WP","GB-GOV-10-EDCTP2_PM","GB-GOV-10-EDCTP2_Scheme7","GB-GOV-10-EDCTP2_Scheme8"], "related-activity.type":["2","2","2","2","2","2","2","2"], "related_activity_type":["2","2","2","2","2","2","2","2"], "conditions.attached":false, "conditions_attached":"0", "reporting-org.type.name":"Government", "reporting_org_type_name":"Government", "recipient-region.name":["Developing countries, unspecified"], "recipient_region_name":["Developing countries, unspecified"], "default-aid-type.name":["Project-type interventions"], "default_aid_type_category_name":["Project-type interventions"], "tag.vocabulary.name":["Reporting Organisation"], "title.narrative.first":"European and Developing Countries Clinical Trials Partnership (EDCTP) phase II", "title_narrative_first":"European and Developing Countries Clinical Trials Partnership (EDCTP) phase II", "activity-date.start-planned":"2017-11-07T00:00:00Z", "activity_date_start_planned":"Tue Nov 07 00:00:00 UTC 2017", "activity_date_start_planned_f":"2017-11-07T00:00:00Z", "activity-date.common.start":"2017-11-07T00:00:00Z", "activity_date_start_common":"Tue Nov 07 00:00:00 UTC 2017", "activity_date_start_common_f":"2017-11-07T00:00:00Z", "activity-date.start-actual":"2017-11-07T00:00:00Z", "activity_date_start_actual":"Tue Nov 07 00:00:00 UTC 2017", "activity_date_start_actual_f":"2017-11-07T00:00:00Z", "activity-date.end-planned":"2027-03-31T00:00:00Z", "activity_date_end_planned":"Wed Mar 31 00:00:00 UTC 2027", "activity_date_end_planned_f":"2027-03-31T00:00:00Z", "activity-date.common.end":"2027-03-31T00:00:00Z", "activity_date_end_common":"Wed Mar 31 00:00:00 UTC 2027", "activity_date_end_common_f":"2027-03-31T00:00:00Z", "activity-status.text":"Implementation", "activity_status_text":"Implementation", "dataset.id":"bce0347a-c08e-4d93-86ce-c44d7adc5c93", "dataset_iati_id":"bce0347a-c08e-4d93-86ce-c44d7adc5c93", "dataset.name":"dhsc-activities-ghr", "dataset_name":"dhsc-activities-ghr", "dataset.extras.iati_version":"2.03", "dataset.resources.hash":"5a2fa4a2f378e3034bb8e88e541b337f92b20e0f", "dataset.resources.url":"https://dhsc-govuk.github.io/iati-oda-spending-metadata/dhsc-activities-ghr.xml", "activity-date.quarter":[4,4,1], "document-link.document-date.quarter":[4,4,4,2,1,3,1,3,4,4,1], "document-link.category-codes-combined":["A07,A08","A12","A07,A08","A07,A08,A02,A05","A07,A08","A07,A08","A07,A08","A07,A08","A09,A04","A06","A07"], "child-aggregation.budget.value":9.34331E7, "child_aggregation_budget_value":9.34331E7, "activity-plus-child-aggregation.budget.value":9.34331E7, "activity_plus_child_aggregation_budget_value":9.34331E7, "child-aggregation.budget.currency":"USD", "child_aggregation_budget_currency":"USD", "activity-plus-child-aggregation.budget.currency":"USD", "activity_plus_child_aggregation_budget_currency":"USD", "child-aggregation.budget.value-usd":1.2299077201845868E8, "child_aggregation_budget_value_usd":1.2299077201845868E8, "activity-plus-child-aggregation.budget.value-usd":1.2299077201845868E8, "activity_plus_child_aggregation_budget_value_usd":1.2299077201845868E8, "child-aggregation.budget.value-gbp":9.34331E7, "child_aggregation_budget_value_gbp":9.34331E7, "activity-plus-child-aggregation.budget.value-gbp":9.34331E7, "activity_plus_child_aggregation_budget_value_gbp":9.34331E7, "child-aggregation.outgoing-commitment.value":9.34331E7, "child_aggregation_commitment_value":9.34331E7, "activity-plus-child-aggregation.outgoing-commitment.value":9.34331E7, "activity_plus_child_aggregation_commitment_value":9.34331E7, "child-aggregation.outgoing-commitment.currency":"USD", "child_aggregation_commitment_currency":"USD", "activity-plus-child-aggregation.outgoing-commitment.currency":"USD", "activity_plus_child_aggregation_commitment_currency":"USD", "child-aggregation.outgoing-commitment.value-usd":1.2111385814782847E8, "child_aggregation_commitment_value_usd":1.2111385814782847E8, "activity-plus-child-aggregation.outgoing-commitment.value-usd":1.2111385814782847E8, "activity_plus_child_aggregation_commitment_value_usd":1.2111385814782847E8, "child-aggregation.outgoing-commitment.value-gbp":9.34331E7, "child_aggregation_commitment_value_gbp":9.34331E7, "activity-plus-child-aggregation.outgoing-commitment.value-gbp":9.34331E7, "activity_plus_child_aggregation_commitment_value_gbp":9.34331E7, "child-aggregation.disbursement.value":9.34331E7, "child_aggregation_disbursement_value":9.34331E7, "activity-plus-child-aggregation.disbursement.value":9.34331E7, "activity_plus_child_aggregation_disbursement_value":9.34331E7, "child-aggregation.disbursement.currency":"USD", "child_aggregation_disbursement_currency":"USD", "activity-plus-child-aggregation.disbursement.currency":"USD", "activity_plus_child_aggregation_disbursement_currency":"USD", "child-aggregation.disbursement.value-usd":1.216031567614903E8, "child_aggregation_disbursement_value_usd":1.216031567614903E8, "activity-plus-child-aggregation.disbursement.value-usd":1.216031567614903E8, "activity_plus_child_aggregation_disbursement_value_usd":1.216031567614903E8, "child-aggregation.disbursement.value-gbp":9.34331E7, "child_aggregation_disbursement_value_gbp":9.34331E7, "activity-plus-child-aggregation.disbursement.value-gbp":9.34331E7, "activity_plus_child_aggregation_disbursement_value_gbp":9.34331E7, "json.reporting-org":"{\"ref\": \"GB-GOV-10\", \"type\": 10, \"narrative\": \"UK - Department of Health and Social Care (DHSC)\", \"narrative.lang\": \" \"}", "json.title":"{\"narrative\": \"European and Developing Countries Clinical Trials Partnership (EDCTP) phase II\", \"narrative.lang\": \" \"}", "json.description":["{\"type\": 1, \"narrative\": \"The UK Department of Health and Social Care (DHSC) funds outstanding global health research through the National Institute for Health and Care Research (NIHR). The NIHR provided funding to the European and Developing Countries Clinical Trials Partnership (EDCTP) which aims to support collaborative research that accelerates the clinical development of new or improved interventions to prevent or treat poverty related diseases as well as emerging and re-emerging infectious diseases affecting sub-Saharan Africa. The NIHR has supported research calls as part of the 2016, 2017 and 2018 workplans, in addition to programme management activities associated with enhancing the wider programme.\", \"narrative.lang\": \" \"}","{\"type\": 2, \"narrative\": \"1) Increase the number of new or improved medical interventions for poverty-related diseases (PRDs), including neglected ones; 2) Strengthen cooperation with sub-Saharan African countries, in particular on building their capacity for conducting clinical trials in compliance with fundamental ethical principles and relevant national, EU and international legislation; 3) Better coordinate, align and, where appropriate, integrate relevant national programmes to increase the cost-effectiveness of European public investments; 4) Extend international cooperation with other public and private partners to ensure that the impact of all research is maximised and that synergies can be taken into consideration and to achieve leveraging of resources and investments; 5) Increase impact due to effective cooperation with relevant EU initiatives, including its development assistance.\", \"narrative.lang\": \" \"}"], "json.participating-org":["{\"ref\": \"GB-GOV-10\", \"role\": 1, \"type\": 10, \"narrative\": \"UK - Department of Health and Social Care (DHSC)\", \"narrative.lang\": \" \"}","{\"ref\": \"GB-GOV-10\", \"role\": 2, \"type\": 10, \"narrative\": \"UK - Department of Health and Social Care (DHSC)\", \"narrative.lang\": \" \"}","{\"ref\": \"GB-GOV-10\", \"role\": 3, \"type\": 10, \"narrative\": \"UK - Department of Health and Social Care (DHSC)\", \"narrative.lang\": \" \"}","{\"ref\": \"NL-KVK-60471700\", \"role\": 4, \"type\": 30, \"narrative\": \"European and Developing Countries Clinical Trials Partnership (EDCTP)\", \"narrative.lang\": \" \"}","{\"ref\": \"NL-KVK-60471700\", \"role\": 4, \"type\": 30, \"narrative\": \"European and Developing Countries Clinical Trials Partnership (EDCTP)\", \"narrative.lang\": \" \"}","{\"ref\": \"NL-KVK-60471700\", \"role\": 4, \"type\": 30, \"narrative\": \"European and Developing Countries Clinical Trials Partnership (EDCTP)\", \"narrative.lang\": \" \"}","{\"ref\": \"NL-KVK-60471700\", \"role\": 4, \"type\": 30, \"narrative\": \"European and Developing Countries Clinical Trials Partnership (EDCTP)\", \"narrative.lang\": \" \"}","{\"ref\": \"NL-KVK-60471700\", \"role\": 4, \"type\": 30, \"narrative\": \"European and Developing Countries Clinical Trials Partnership (EDCTP)\", \"narrative.lang\": \" \"}","{\"ref\": \"NL-KVK-60471700\", \"role\": 4, \"type\": 30, \"narrative\": \"European and Developing Countries Clinical Trials Partnership (EDCTP)\", \"narrative.lang\": \" \"}","{\"ref\": \"NL-KVK-60471700\", \"role\": 4, \"type\": 30, \"narrative\": \"European and Developing Countries Clinical Trials Partnership (EDCTP)\", \"narrative.lang\": \" \"}","{\"ref\": \"NL-KVK-60471700\", \"role\": 4, \"type\": 30, \"narrative\": \"European and Developing Countries Clinical Trials Partnership (EDCTP)\", \"narrative.lang\": \" \"}"], "json.activity-date":["{\"iso-date\": \"2017-11-07\", \"type\": 1}","{\"iso-date\": \"2017-11-07\", \"type\": 2}","{\"iso-date\": \"2027-03-31\", \"type\": 3}"], "json.contact-info":["{\"type\": 1, \"organisation\": {\"narrative\": \"UK - Department of Health and Social Care (DHSC)\", \"narrative.lang\": \" \"}, \"department\": {\"narrative\": \"Science, Research and Evidence\", \"narrative.lang\": \" \"}, \"person-name\": {\"narrative\": \"Global Health Research Programme\", \"narrative.lang\": \" \"}, \"email\": \"GlobalHealthResearch@dhsc.gov.uk\", \"website\": \"https://www.nihr.ac.uk/funding-and-support/global-health-research/\", \"mailing-address\": {\"narrative\": \"7th Floor South Wing, 39 Victoria Street, London, SW1H 0EU\", \"narrative.lang\": \" \"}}"], "json.recipient-region":["{\"code\": 998, \"vocabulary\": 1}"], "json.sector":["{\"code\": 12182, \"percentage\": 100, \"vocabulary\": 1, \"narrative\": \"Medical research\", \"narrative.lang\": \" \"}"], "json.tag":["{\"code\": \"RI\", \"vocabulary\": 99, \"vocabulary-uri\": \"https://devtracker.fcdo.gov.uk/custom-codes\", \"narrative\": \"Research and Innovation\", \"narrative.lang\": \" \"}"], "json.default-aid-type":["{\"code\": \"C01\"}"], "json.document-link":["{\"format\": \"application/pdf\", \"url\": \"http://www.edctp.org/web/app/uploads/2018/09/Tackling-infectious-disease-in-sub-Saharan-Africa_EDCTP-funded-clinical-studies-for-medical-interventions-2003-2018-4.pdf\", \"title\": {\"narrative\": \"2003- 2018 review \", \"narrative.lang\": \" \"}, \"category\": [{\"code\": \"A07\"}, {\"code\": \"A08\"}], \"language\": {\"code\": \"en\"}, \"document-date\": [{\"iso-date\": \"2017-11-07\"}]}","{\"format\": \"text/html\", \"url\": \"http://www.edctp.org/\", \"title\": {\"narrative\": \"Activity webpage \", \"narrative.lang\": \" \"}, \"category\": [{\"code\": \"A12\"}], \"language\": {\"code\": \"en\"}, \"document-date\": [{\"iso-date\": \"2017-11-07\"}]}","{\"format\": \"application/pdf\", \"url\": \"https://drive.google.com/open?id=1vwm9Vtpday3tGQbCO2lRlmhUB8xM9Rqd&usp=drive_copy\", \"title\": {\"narrative\": \"DHSC contribution to EDCTP Report - 1 Jan 2018 to 30 Apr 2020\", \"narrative.lang\": \" \"}, \"category\": [{\"code\": \"A07\"}, {\"code\": \"A08\"}], \"language\": {\"code\": \"en\"}, \"document-date\": [{\"iso-date\": \"2020-11-11\"}]}","{\"format\": \"application/pdf\", \"url\": \"https://drive.google.com/file/d/1gKjBMegVAsBuyERmpqiDEgK0C-dBGmxF/view?usp=drive_link\", \"title\": {\"narrative\": \"EDCTP Phase 2 and 3 2023-2025 Annual Review\", \"narrative.lang\": \" \"}, \"category\": [{\"code\": \"A07\"}, {\"code\": \"A08\"}, {\"code\": \"A02\"}, {\"code\": \"A05\"}], \"language\": {\"code\": \"en\"}, \"document-date\": [{\"iso-date\": \"2025-05-26\"}]}","{\"format\": \"application/pdf\", \"url\": \"https://drive.google.com/open?id=1SbewTAkqcYirhwnehs4gNHznKX9ssZy1&usp=drive_copy\", \"title\": {\"narrative\": \"EDCTP2 Annual Review 2020-2021\", \"narrative.lang\": \" \"}, \"category\": [{\"code\": \"A07\"}, {\"code\": \"A08\"}], \"language\": {\"code\": \"en\"}, \"document-date\": [{\"iso-date\": \"2024-01-17\"}]}","{\"format\": \"application/pdf\", \"url\": \"https://drive.google.com/file/d/15sPEqysmGVYx1GOMrGsL0GXkyEVRoP8l/view?usp=drive_link\", \"title\": {\"narrative\": \"EDCTP2 Annual Review 2020-21\", \"narrative.lang\": \" \"}, \"category\": [{\"code\": \"A07\"}, {\"code\": \"A08\"}], \"language\": {\"code\": \"en\"}, \"document-date\": [{\"iso-date\": \"2024-07-01\"}]}","{\"format\": \"application/pdf\", \"url\": \"https://drive.google.com/open?id=1ousH2dKnWWBzuFpJuDFuAg5TBxfu_o8M&usp=drive_copy\", \"title\": {\"narrative\": \"EDCTP2 Annual Review 2021-2022\", \"narrative.lang\": \" \"}, \"category\": [{\"code\": \"A07\"}, {\"code\": \"A08\"}], \"language\": {\"code\": \"en\"}, \"document-date\": [{\"iso-date\": \"2024-01-17\"}]}","{\"format\": \"application/pdf\", \"url\": \"https://drive.google.com/file/d/1BUnsAUNnRVLEuLbkhPHPPBJE-W7S37tQ/view?usp=drive_link\", \"title\": {\"narrative\": \"EDCTP2 Annual Review 2021-22\", \"narrative.lang\": \" \"}, \"category\": [{\"code\": \"A07\"}, {\"code\": \"A08\"}], \"language\": {\"code\": \"en\"}, \"document-date\": [{\"iso-date\": \"2024-07-01\"}]}","{\"format\": \"application/pdf\", \"url\": \"https://drive.google.com/open?id=1PdErJJpupm0rsFpEHypFzPd01LQ5LHLK&usp=drive_copy\", \"title\": {\"narrative\": \"Memorandum of Understanding\", \"narrative.lang\": \" \"}, \"category\": [{\"code\": \"A09\"}, {\"code\": \"A04\"}], \"language\": {\"code\": \"en\"}, \"document-date\": [{\"iso-date\": \"2023-12-08\"}]}","{\"format\": \"text/html\", \"url\": \"http://www.edctp.org/projects-2/edctp2-projects/\", \"title\": {\"narrative\": \"Projects by call for proposal\", \"narrative.lang\": \" \"}, \"category\": [{\"code\": \"A06\"}], \"language\": {\"code\": \"en\"}, \"document-date\": [{\"iso-date\": \"2017-11-07\"}]}","{\"format\": \"application/pdf\", \"url\": \"https://drive.google.com/file/d/1TcFegu9QL5i3h7EIzUWIous4Ci2zLVoM/view?usp=drive_link\", \"title\": {\"narrative\": \"GHR Portfolio Evaluation\", \"narrative.lang\": \" \"}, \"category\": [{\"code\": \"A07\"}], \"language\": {\"code\": \"en\"}, \"document-date\": [{\"iso-date\": \"2024-03-01\"}]}"], "json.related-activity":["{\"ref\": \"GB-GOV-10-EDCTP2_2016WP\", \"type\": 2}","{\"ref\": \"GB-GOV-10-EDCTP2_2017WP\", \"type\": 2}","{\"ref\": \"GB-GOV-10-EDCTP2_2018WP\", \"type\": 2}","{\"ref\": \"GB-GOV-10-EDCTP2_2020WP\", \"type\": 2}","{\"ref\": \"GB-GOV-10-EDCTP2_2024WP\", \"type\": 2}","{\"ref\": \"GB-GOV-10-EDCTP2_PM\", \"type\": 2}","{\"ref\": \"GB-GOV-10-EDCTP2_Scheme7\", \"type\": 2}","{\"ref\": \"GB-GOV-10-EDCTP2_Scheme8\", \"type\": 2}"], "json.conditions":"{\"attached\": 0}", "related_budget_value":[16765600,1310175,27000000,1345731,10000000,21742000,1746900,4800000,1746900,1759385,1409500,790909,2176000,840000], "related_budget_period_start_quarter":[2,2,2,2,2,2,2,2,2,2,2,2,2,2], "related_budget_period_end_quarter":[1,1,1,1,1,1,1,1,1,1,1,1,1,1], "related_budget_period_start_iso_date":["2017-04-01T00:00:00Z","2023-04-01T00:00:00Z","2018-04-01T00:00:00Z","2023-04-01T00:00:00Z","2018-04-01T00:00:00Z","2019-04-01T00:00:00Z","2023-04-01T00:00:00Z","2020-04-01T00:00:00Z","2023-04-01T00:00:00Z","2023-04-01T00:00:00Z","2018-04-01T00:00:00Z","2023-04-01T00:00:00Z","2022-04-01T00:00:00Z","2022-04-01T00:00:00Z"], "related_budget_period_end_iso_date":["2018-03-31T00:00:00Z","2024-03-31T00:00:00Z","2019-03-31T00:00:00Z","2024-03-31T00:00:00Z","2019-03-31T00:00:00Z","2020-03-31T00:00:00Z","2024-03-31T00:00:00Z","2021-03-31T00:00:00Z","2024-03-31T00:00:00Z","2024-03-31T00:00:00Z","2019-03-31T00:00:00Z","2024-03-31T00:00:00Z","2023-03-31T00:00:00Z","2023-03-31T00:00:00Z"], "id":"ead5ed87-281c-4a77-93c5-a7bfe7509280", "related_activity_context":"ID: GB-GOV-10-EDCTP2\nTitle: European and Developing Countries Clinical Trials Partnership (EDCTP) phase II\nDescription: The UK Department of Health and Social Care (DHSC) funds outstanding global health research through the National Institute for Health and Care Research (NIHR). The NIHR provided funding to the European and Developing Countries Clinical Trials Partnership (EDCTP) which aims to support collaborative research that accelerates the clinical development of new or improved interventions to prevent or treat poverty related diseases as well as emerging and re-emerging infectious diseases affecting sub-Saharan Africa. The NIHR has supported research calls as part of the 2016, 2017 and 2018 workplans, in addition to programme management activities associated with enhancing the wider programme.. 1) Increase the number of new or improved medical interventions for poverty-related diseases (PRDs), including neglected ones; 2) Strengthen cooperation with sub-Saharan African countries, in particular on building their capacity for conducting clinical trials in compliance with fundamental ethical principles and relevant national, EU and international legislation; 3) Better coordinate, align and, where appropriate, integrate relevant national programmes to increase the cost-effectiveness of European public investments; 4) Extend international cooperation with other public and private partners to ensure that the impact of all research is maximised and that synergies can be taken into consideration and to achieve leveraging of resources and investments; 5) Increase impact due to effective cooperation with relevant EU initiatives, including its development assistance.\n \n ID: GB-GOV-10-EDCTP2_2016WP\nTitle: European and Developing Countries Clinical Trials Partnership (EDCTP) phase II: funding for 2016 work plan\nDescription: The UK Department of Health and Social Care (DHSC) funds outstanding global health research through the National Institute for Health and Care Research (NIHR). The NIHR provided funding to the European and Developing Countries Clinical Trials Partnership (EDCTP) which aims to support collaborative research that accelerates the clinical development of new or improved interventions to prevent or treat poverty related as well as emerging and re-emerging infectious diseases affecting sub-Saharan Africa. NIHR has supported research as part of the 2016 Workplan focussed on, ‘Research and clinical management of patients in PRD epidemics in sub-Saharan Africa Clinical trials’ and ‘Operational research studies to optimise the use of products for poverty-related diseases in mothers, newborns, children and/or adolescents’. This activity is a component of European and Developing Countries Clinical Trials Partnership (EDCTP) phase II programme (GB-GOV-10-EDCTP2).. 1) Support the establishment of a multidisciplinary consortium able to provide accelerated evidence for the optimal clinical management of patients and for guiding the public health response to any severe infectious outbreak caused by pathogens with pandemic potential or that may cause significant damage to health and socio-economics in Africa (including antimicrobial-resistant pathogens); 2) To optimise the use, delivery and access to poverty-related disease medicinal products in sub-Saharan Africa for mothers, newborns, children and/or adolescents. Supported projects should contribute to a better understanding of the role of PRDs in maternal, neonatal, child, and adolescent mortality and morbidity, as well as the barriers for the optimal effectiveness of health products, such as existing drugs or vaccines against these diseases in sub-Saharan Africa.\n \n ID: GB-GOV-10-EDCTP2_2017WP\nTitle: European and Developing Countries Clinical Trials Partnership (EDCTP) phase II: funding for 2017 work plan\nDescription: The UK Department of Health and Social Care (DHSC) funds outstanding global health research through the National Institute for Health and Care Research (NIHR). The NIHR provided funding to the European and Developing Countries Clinical Trials Partnership (EDCTP) which aims to support collaborative research that accelerates the clinical development of new or improved interventions to prevent or treat poverty-related diseases as well as emerging and re-emerging infectious diseases affecting sub-Saharan Africa. NIHR has supported research as part of the 2017 Workplan focussed on: ‘Strategic Actions Supporting Large-Scale Clinical Trials’ and ‘Clinical Trials to reduce health inequities in pregnant women, newborns and children’. This activity is a component of European and Developing Countries Clinical Trials Partnership (EDCTP) phase II programme (GB-GOV-10-EDCTP2).. 1) support strategic actions (clinical research activities) that are part of a large-scale clinical trial with the potential to achieve rapid advances in the clinical development of new or improved medical interventions (drugs, diagnostics, vaccines, microbicides) for poverty related diseases; 2) accelerate the adaption and/or optimisation of treatment and prevention products (excluding vaccines) for povertyrelated diseases in sub-Saharan Africa for use in pregnant women, newborns and/or children.\n \n ID: GB-GOV-10-EDCTP2_2018WP\nTitle: European and Developing Countries Clinical Trials Partnership (EDCTP) phase II: funding for 2018 work plan\nDescription: The UK Department of Health and Social Care (DHSC) funds outstanding global health research through the National Institute for Health and Care Research (NIHR). The NIHR provided funding to the European and Developing Countries Clinical Trials Partnership (EDCTP) which aims to support collaborative research that accelerates the clinical development of new or improved interventions to prevent or treat poverty related as well as emerging and re-emerging infectious diseases affecting sub-Saharan Africa. NIHR has supported research as part of the 2018 Workplan focussed on: ‘Advances in product development for effective prevention, treatment and management of co-infections and co-morbidities’; ‘Diagnostic tools for poverty-related diseases Challenge’; and \"Vaccines for diarrhoeal diseases or lower respiratory tract infections\". This activity is a component of European and Developing Countries Clinical Trials Partnership (EDCTP) phase II programme (GB-GOV-10-EDCTP2).. 1) Support actions that lead to improvements in the prevention, treatment and/or clinical management of co-infections and co-morbidities in sub-Saharan Africa; 2) provide funding to projects focusing on validation of clinical performance and/or implementation of new or improved diagnostic tools and technologies for the detection of any of the PRDs including co-infections 3) improve the performance of diagnosis, prediction, monitoring, intervention or assessment of therapeutic response, with a significant impact on clinical decision and health outcomes 4) contribute towards the reduction of the burden of diarrhoeal diseases or lower respiratory tract infections in sub-Saharan Africa and lead to the advancement of vaccine candidates along the product development pipeline.\n \n ID: GB-GOV-10-EDCTP2_2020WP\nTitle: European and Developing Countries Clinical Trials Partnership (EDCTP) phase II: funding for 2020 work plan\nDescription: The UK Department of Health and Social Care (DHSC) funds outstanding global health research through the National Institute for Health and Care Research (NIHR). The NIHR provided funding to the European and Developing Countries Clinical Trials Partnership (EDCTP) which aims to support collaborative research that accelerates the clinical development of new or improved interventions to prevent or treat poverty related as well as emerging and re-emerging infectious diseases affecting sub-Saharan Africa. NIHR has supported research as part of the 2020 Workplan focussed on: ‘Mobilisation of funding for COVID-19 research in sub-Saharan Africa’; ‘Addressing gender and diversity gaps in clinical research capacity at the EDCTP Regional Networks of Excellence; and \"Capacity development for disease outbreak and epidemic response in sub-Saharan Africa, in collaboration with Africa Centres for Disease Control and Prevention (Africa CDC)\". This activity is a component of European and Developing Countries Clinical Trials Partnership (EDCTP) phase II programme (GB-GOV-10-EDCTP2). . The activities of the EDCTP2 programme will contribute towards achieving the following five specific objectives: Increase the number of new or improved medical interventions for poverty-related diseases (PRDs), including neglected ones; Strengthen cooperation with sub-Saharan African countries, in particular on building their capacity for conducting clinical trials in compliance with fundamental ethical principles and relevant national, EU and international legislation; Better coordinate, align and, where appropriate, integrate relevant national programmes to increase the cost-effectiveness of European public investments; Extend international cooperation with other public and private partners to ensure that the impact of all research is maximised and that synergies can be taken into consideration and to achieve leveraging of resources and investments; Increase impact due to effective cooperation with relevant EU initiatives, including its development assistance.\n \n ID: GB-GOV-10-EDCTP2_2024WP\nTitle: European and Developing Countries Clinical Trials Partnership (EDCTP) phase II: funding for 2024 work plan\nDescription: The UK Department of Health and Social Care (DHSC) funds outstanding global health research through the National Institute for Health and Care Research (NIHR). The NIHR provided funding to the European and Developing Countries Clinical Trials Partnership (EDCTP) which aims to support collaborative research that accelerates the clinical development of new or improved interventions to prevent or treat poverty related as well as emerging and re-emerging infectious diseases affecting sub-Saharan Africa. NIHR has supported research capacity strengthening and training in sub-Saharan Africa, related to strengthening clinical trials capacity as part of the 2024 Workplan focussed on: \n•\tSupport for an updated EDCTP Masters scholarship scheme for candidates from sub-Saharan Africa to undertake Masters degrees with an option for an associated project or policy activity \n•\tSupport for candidates from sub-Saharan Africa to attend training specific to improving clinical trial capability in sub-Saharan Africa. 1.\tSupport for an updated EDCTP Masters scholarship scheme for candidates from sub-Saharan Africa to attend relevant Master programmes in subject areas relevant to clinical research, epidemiology, clinical trials and global health, with an associated option for a further research or policy project\n2.\tScholarships for: \n(i) candidates from sub-Saharan Africa to attend the 2-week training programme, Advanced Course of Vaccinology (ADVAC) for scientists and decision-makers involved in vaccine development, new vaccination strategies or in associated policy areas\n(ii) Strengthening the EDCTP Regional Networks of Excellence through bioprocessing training \n \n ID: GB-GOV-10-EDCTP2_PM\nTitle: European and Developing Countries Clinical Trials Partnership (EDCTP) phase II: funding for programme management activities \nDescription: The UK Department of Health and Social Care (DHSC) funds outstanding global health research through the National Institute for Health and Care Research (NIHR). The European & Developing Countries Clinical Trials Partnership (EDCTP) funds clinical research to accelerate the development of new or improved drugs, vaccines, microbicides and diagnostics against HIV/AIDS, tuberculosis and malaria as well as other poverty-related infectious diseases in sub-Saharan Africa, with a focus on phase II and III clinical trials. The NIHR provided a funding contribution to EDCTP 2 programme management activities. This activity is a component of European and Developing Countries Clinical Trials Partnership (EDCTP) phase II programme (GB-GOV-10-EDCTP2).. Support the European & Developing Countries Clinical Trials Partnership to effectively deliver EDCTP2 programmes.\n \n ID: GB-GOV-10-EDCTP2_Scheme7\nTitle: European and Developing Countries Clinical Trials Partnership (EDCTP) phase II: Support for The GloPID-R Secretariat\nDescription: The UK Department of Health and Social Care (DHSC) funds outstanding global health research through the National Institute for Health and Care Research (NIHR). The NIHR provided funding to European and Developing Countries Clinical Trials Partnership (EDCTP) which aims to support collaborative research that accelerates the clinical development of new or improved interventions to prevent or treat poverty related as well as emerging and re-emerging infectious diseases affecting sub-Saharan Africa. NIHR has supported the research as part of the the Global Research Collaboration for Infectious Diseases Preparedness (GloPID-R) Secretariat on Pandemic Preparedness: Analytical Capacity and Funding Tracking programme (Pandemic PACT). This activity is a component of European and Developing Countries Clinical Trials Partnership (EDCTP) phase II programme (GB-GOV-10-EDCTP2). . Support to develop the creation of Pandemic Analytical Capacity and Funding Tracking Programme (Pandemic PACT) database which build on the COVID CIRCLE research tracker established during the COVID-19 pandemic. Pandemic PACT will develop a research funding tracking and analysis capability for a range of emerging infections, in particular focussed on those primariliy affection low and middle-income country poulations, with the outputs linked to major funders, decision makers and WHO. \n \n ID: GB-GOV-10-EDCTP2_Scheme8\nTitle: European and Developing Countries Clinical Trials Partnership (EDCTP) phase II: WHO support for World Health Assembly Clinical Trials Resolution\nDescription: The UK Department of Health and Social Care (DHSC) funds outstanding global health research through the National Institute for Health and Care Research (NIHR). The NIHR provided funding to European and Developing Countries Clinical Trials Partnership (EDCTP) which aims to support collaborative research that accelerates the clinical development of new or improved interventions to prevent or treat poverty related as well as emerging and re-emerging infectious diseases affecting sub-Saharan Africa. NIHR has supported through EDCTP2 proposed actions for WHO to support implementation of the World Health Assembly Clinical Trials Resolution. This activity is a component of European and Developing Countries Clinical Trials Partnership (EDCTP) phase II programme (GB-GOV-10-EDCTP2). . Support to WHO to develop global normative implementation guidance to focus clinical trials on key design features that will increase the quality of evidence for decision-making and increase trial capacity, particularly focussed on low and middle-income country settings, as part of implementaion of the World Health Assembly Resolution on Clinical Trials (WAH 75.8). \n\n\n", "_version_":1861587665205329920 }] } }